Sign inJoin waitlistJoin the waitlist

Matthew Yurgelun

Director, Lynch Syndrome Center · Mass General Brigham

Credentials: · · · ·

History

Lynch Syndrome Center · Mass General Brigham
Present
Dana-Farber Cancer Institute Center for Cancer Genetics & Prevention · Mass General Brigham
Present
Mass General Brigham
Present

Beth Israel Deaconess Medical Center
2009–2011
Internal Medicine
Beth Israel Deaconess Medical Center
2006–2009
Columbia Univ Coll of Phys & Surgeons
2002–2006

Research

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 914 citations
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
Journal of Clinical Oncology · 2017 · First of 18 authors · 414 citations
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
Journal of the National Comprehensive Cancer Network · 2020 · 371 citations

Sapna Syngal
42 papers
Douglas Rubinson
21 papers
Brian Wolpin
20 papers
Kimmie Ng
19 papers
Leah Biller
17 papers · 4 as a fellow
James Cleary
16 papers
Judy Garber
16 papers
Thomas Abrams
16 papers
Jonathan Nowak
15 papers · 1 as a fellow
Jeffrey Meyerhardt
14 papers
Nadine Jackson
14 papers
Kimberly Perez
13 papers

Clinical trials

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Principal investigator · Recruiting · Early phase 1
Dana-Farber Cancer Institute
2023–2041
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Principal investigator · Active not recruiting
Dana-Farber Cancer Institute
2017–2028
The Cancer of the Pancreas Screening-5 CAPS5)Study
Sub-investigator · Recruiting · Phase 3
Johns Hopkins University
2014–2029